News

Leerink Partners Reiterates a Buy Rating on Relay Therapeutics (RLAY) With a $12 PT

Relay Therapeutics, Inc. (NASDAQ:RLAY) is one of the top strong buy stocks under $5 to buy now. Leerink Partners analyst ...